BioProcess International (BPI)
Hynes Convention Center, Boston
23-26 September 2024
Watch Michael Barnes’ presentation on “Data cash flow – converting your bioprocessing liability into next-gen assets by integrating product and process insights across the entire biopharmaceutical lifecycle” from September 24, within the Manufacturing Strategy track.
Transform your data into insight to accelerate through the BioPharma lifecycle from research to manufacturing
At IDBS, we understand the importance of productivity, efficiency and compliance across the product lifecycle, and empower our customers to unlock the power of data for faster and smarter decision-making. Designed and deployed with our customers’ mission front and center, we ensure the IDBS platform offers true digital transformation success – enabling BioPharma organizations to focus on cutting-edge science.
Watch our Scientific Track Presentation: “Data Cash Flow – converting your bioprocessing liability into next gen assets by integrating product and process insights across the entire biopharmaceutical lifecycle” on the right.
As ill-fated hopes from digital strategies (including AI/ML) fail to propel organizations to being first to market, many are left wondering why. With the diversity of data and software needs from Research through Manufacturing, well-intentioned companies quickly find that digital collection is far easier than digital connection. So how can groups glean transformative and meaningful insights in their pursuit of cost-effective and robust processes, with disjointed data management? How can biopharma expand their process understanding to better bridge the chasm between development and production groups, and enable more successful tech transfers?
Join us as we discuss several bioprocessing strategies including the benefits of using of an integrated digital data backbone, the simplicity of a continuous tech transfer process, and how an advanced analytics engine can facilitate comprehensive reporting and analysis for users of all backgrounds.
Watch the Webinar
Meet our speaker

Michael Barnes, Lead Solutions Consultant, IDBS
A multidisciplinary bench scientist having worked in various roles/companies, from isolating rare & underrepresented cancers at the Broad Institute, to automating cell-based toxicology assays in a CRO setting.
Prior to joining IDBS, Michael spent ~3 years in Pfizer’s BioProcess R&D Cell Line Development group, working to evaluate different vectors/expression systems and investigate phenotypic changes at a genotypic level.
About BioProcess International: Unlock the Future of Bioprocessing: Harness innovative technologies, improve efficiencies and reduce costs for your biologics. Experience next-generation platforms and processes with the people that empower you to deliver transformative therapies with precision, quality and scalability.













